Proexp Pharma Private Limited
About Proexp Pharma Private Limited
Data last updated:
Proexp Pharma Private Limited is a private limited company based in Pune, , India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24299PN2021PTC204534.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sanjay Mahadeo Gade and Vilas Hareshwar Dahanukar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Puraniks Abitante Flat F/1401 Bavdhan Budruk (Bk), Pune, Maharashtra, India – 411021.
As per the financials filed for FY 2024, the company reported a revenue of ₹48.01 Lakh, a decline of 27% compared to the previous year. For the same year it recorded a net profit of ₹13,406 (net margin 0.3%) and EBITDA of ₹22,524 (EBITDA margin 0.5%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPuraniks Abitante Flat F/1401 Bavdhan Budruk (Bk), Pune, Maharashtra, India – 411021
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Proexp Pharma Private Limited
The main business activity of Proexp Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Proexp Pharma Private Limited FY 2025 filings available
Proexp Pharma Private Limited reported revenue of ₹48.01 Lakh (down 27% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Proexp Pharma Private Limited
Revenue fell 27% in the latest year. EBITDA fell 99% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Proexp Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹22,524 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹13,406 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Proexp Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.5% | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Proexp Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Proexp Pharma Private Limited
Proexp Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Iluz Medisciences Private Limited | ₹48.39 Lakh (FY 2024) | •••• | •••• | 25.0% | •••• | Pune, Maharashtra, India |
| Fine Bio-Science Private Limited | ₹48.33 Lakh (FY 2025) | •••• | •••• | 20.0% | •••• | Ahmedabad, Gujarat, India |
| Vpa Pharmaceutical Private Limited | ₹48.2 Lakh (FY 2023) | •••• | •••• | -21.0% | •••• | Rai, Haryana, India |
| Venshiv Pharma Chem Private Limited | ₹48.14 Lakh (FY 2025) | •••• | •••• | -78.0% | •••• | Hyderabad, Telangana, India |
| Medlife Formulations Private Limited | ₹48.13 Lakh (FY 2025) | •••• | •••• | -78.0% | •••• | Navi Mumbai, Maharashtra, India |
| Proexp Pharma Private Limited this company | ₹48.01 Lakh (FY 2024) | •••• | •••• | -27.0% | •••• | Pune, Maharashtra, India |
| Maxford Health Care Private Limited | ₹47.94 Lakh (FY 2024) | •••• | •••• | 230.0% | •••• | East Karawal Nagar, Delhi, India |
| Maclife Pharmaceutical Private Limited | ₹47.84 Lakh (FY 2024) | •••• | •••• | 173.0% | •••• | Cachar, Assam, India |
| Vivagenix Private Limited | ₹47.65 Lakh (FY 2025) | •••• | •••• | 145.0% | •••• | Gurugram, Haryana, India |
| Savikalpa Sciences Private Limited | ₹47.61 Lakh (FY 2025) | •••• | •••• | 92.0% | •••• | New Delhi, Delhi, India |
| K J Pioneer Pharma Private Limited | ₹47.58 Lakh (FY 2019) | •••• | •••• | 3044.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Proexp Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Proexp Pharma Private Limited
Proexp Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Mahadeo Gade | Director | 23 Sep 2021 | 5 Years 0 Months | Current |
| Vilas Hareshwar Dahanukar | Director | 23 Sep 2021 | 5 Years 0 Months | Current |
Charges & Borrowings of Proexp Pharma Private Limited
Proexp Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Proexp Pharma Private Limited
Employment history and EPFO contributions of people linked to Proexp Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Proexp Pharma Private Limited
Proexp Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Sanjay Mahadeo Gade was appointed as Director on 23 Sep 2021.
Credit Ratings, Litigation & Regulatory Alerts for Proexp Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Proexp Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Proexp Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Proexp Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Proexp Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Proexp Pharma Private Limited
Proexp Pharma is an active private limited company based in Pune, , India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 September 2021 (5+ years old) and is registered under CIN U24299PN2021PTC204534.
Proexp Pharma reported revenue of ₹48.01 Lakh for FY 2024 (down 27% YoY).
Proexp Pharma has 2 current directors:
- Sanjay Mahadeo Gade - Director
- Vilas Hareshwar Dahanukar - Director
Proexp Pharma reported a net profit of ₹13,406 (net margin 0.3%) and EBITDA of ₹22,524 (EBITDA margin 0.5%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Proexp Pharma is U24299PN2021PTC204534. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Proexp Pharma was incorporated on 23 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Proexp Pharma by revenue are Iluz Medisciences Private Limited, Fine Bio-Science Private Limited, Vpa Pharmaceutical Private Limited, Venshiv Pharma Chem Private Limited, Medlife Formulations Private Limited and 5 more, all in the Pharma industry (Formulations).
Sanjay Mahadeo Gade was appointed as Director on 23 Sep 2021. Vilas Hareshwar Dahanukar was appointed as Director on 23 Sep 2021.
The registered office of Proexp Pharma is at Puraniks Abitante Flat F1401 Bavdhan Budruk Bk, Pune, Maharashtra, India – 411021.
Proexp Pharma has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.
Proexp Pharma operates in the pharma industry, in the drug formulation and development segment.